FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Moderna's Trailing 12-Month Free Cash Flow is $-3,825 Mil, and Market Cap is $42,737 Mil. Therefore, Moderna's FCF Yield % for today is -8.95%.
The historical rank and industry rank for Moderna's FCF Yield % or its related term are showing as below:
MRNA'
s FCF Yield % Range Over the Past 10 Years
Min: -11.5 Med: 0.97 Max: 24.06
Current: -8.95
During the past 8 years, the highest FCF Yield % of Moderna was 24.06%. The lowest was -11.50%. And the median was 0.97%.
MRNA's FCF Yield % is ranked better than 60.3% of 1549
companies
in the Biotechnology industry
Industry Median: -15.5
vs MRNA: -8.95
The historical data trend for Moderna's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Moderna's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Moderna's FCF Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Moderna's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Moderna's FCF Yield % falls into.
Moderna FCF Yield % Calculation
FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Moderna's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Moderna FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Moderna FCF Yield % Related Terms
Thank you for viewing the detailed overview of Moderna's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MRNA has been successfully added to your 